Sichuan Goldstone Asia Pharmaceutical Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 419.79 million compared to CNY 314.99 million a year ago. Revenue was CNY 419.79 million compared to CNY 314.99 million a year ago.

Net income was CNY 143.46 million compared to CNY 66.58 million a year ago. Basic earnings per share from continuing operations was CNY 0.3571 compared to CNY 0.17 a year ago. Diluted earnings per share from continuing operations was CNY 0.3571 compared to CNY 0.17 a year ago.